The commonly recommended subcutaneous GLP 1 injection sites are the abdomen, upper thigh, and upper arm, each offering reliable subcutaneous access for medication delivery when prescribed and used as directed
The only persistent side effect was appetite suppression, which is the intended therapeutic outcome
[31] [32] Additionally, patients with obesity often have undiagnosed or undertreated obstructive sleep apnea, which typically improves with weight loss, though CPAP settings may need adjustment during treatment
At Earth Angel Wellness, semaglutide is used to support appetite regulation, portion control, and sustainable progress
[1] [2] Healthcare providers should emphasize during patient education that "refrigerated" and "frozen" are distinctly different storage conditions, and only refrigeration within the specified range maintains medication integrity and patient safety